Impact of B7-H3 expression on metastasis, immune exhaustion and JAK/STAT and PI3K/AKT pathways in clear cell renal cell carcinoma.

Saved in:
Bibliographic Details
Title: Impact of B7-H3 expression on metastasis, immune exhaustion and JAK/STAT and PI3K/AKT pathways in clear cell renal cell carcinoma.
Authors: Emaldi M; Cancer Department, Biobizkaia Health Research Institute, Barakaldo, Spain.; CIBERER, ISCIII, Madrid, Spain., Rey-Iborra E; Cancer Department, Biobizkaia Health Research Institute, Barakaldo, Spain.; CIBERER, ISCIII, Madrid, Spain., Marín Á; Cancer Department, Biobizkaia Health Research Institute, Barakaldo, Spain., Mosteiro L; Cancer Department, Biobizkaia Health Research Institute, Barakaldo, Spain.; CIBERER, ISCIII, Madrid, Spain.; Department of Pathology, Cruces University Hospital, Barakaldo, Spain., Lecumberri D; Cancer Department, Biobizkaia Health Research Institute, Barakaldo, Spain.; Service of Urology, Urduliz Hospital, Urduliz, Spain., Øyjord T; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway., Roncier N; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway., Mælandsmo GM; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway.; Department of Medical Biology, Faculty of Health Sciences, University of Tromsø, The Arctic University of Norway, Tromsø, Norway., Angulo JC; Service of Urology, Getafe University Hospital, Getafe, Madrid, Spain.; Clinical Department, Faculty of Biomedical Sciences, European University of Madrid, Madrid, Spain., Errarte P; Department of Nursing, Faculty of Medicine and Nursing, University of the Basque Country UPV/EHU, Leioa, Spain., Larrinaga G; Cancer Department, Biobizkaia Health Research Institute, Barakaldo, Spain.; Department of Nursing, Faculty of Medicine and Nursing, University of the Basque Country UPV/EHU, Leioa, Spain., Pulido R; Cancer Department, Biobizkaia Health Research Institute, Barakaldo, Spain.; CIBERER, ISCIII, Madrid, Spain.; Ikerbasque, Basque Foundation for Science, Bilbao, Spain., López JI; Cancer Department, Biobizkaia Health Research Institute, Barakaldo, Spain., Nunes-Xavier CE; Cancer Department, Biobizkaia Health Research Institute, Barakaldo, Spain.; CIBERER, ISCIII, Madrid, Spain.; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway.
Source: Oncoimmunology [Oncoimmunology] 2024 Dec 31; Vol. 13 (1), pp. 2419686. Date of Electronic Publication: 2024 Nov 01.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2162-402X (Electronic) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2162-402X
DOI:10.1080/2162402X.2024.2419686